Skip to main content
TipRanks
Go Ultimate75% OFF

Excelsior Biopharma Inc (6496) Balance Sheet

Excelsior Biopharma Inc Balance Sheet

Excelsior Biopharma Inc's total assets for Q2 2026 were NT$1.42B, a decrease of 0.87% from the previous quarter. TW:6496 total liabilities were NT$728.80M for the fiscal quarter, a 6.49% an increase from the previous quarter. See a summary of the company’s assets, liabilities, and equity.

Balance Sheet
Balance SheetDec 25Dec 24Dec 23Dec 22Dec 21
NT$ 1.48BNT$ 1.58BNT$ 1.58BNT$ 1.71BNT$ 1.84B
NT$ 679.78MNT$ 586.89MNT$ 472.87MNT$ 507.53MNT$ 608.90M
NT$ 804.23MNT$ 991.45MNT$ 1.10BNT$ 1.21BNT$ 1.23B

Currency in TWD

Excelsior Biopharma Inc Liabilities to Assets

0800M1.6B2.4B24 %32 %40 %48 %LiabilitiesLiabilities to Assets202020212022202320242025AssetsLiabilitiesLiabilities to Assets